Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New 'Dual-Mode' Tracer Enables Surgeons to See and Hear Prostate Cancer

By MedImaging International staff writers
Posted on 27 Aug 2025

Prostate cancer is one of the most common cancers in men, with about one in eight Canadian men developing the disease during their lifetime; one in 30 will die from it. More...

Treatment often requires balancing the removal of tumors with the preservation of critical structures such as nerves, the seminal vesicle, bowel, and bladder. Surgeons need more precise tools to detect and remove cancer while reducing the risks of recurrence and surgical complications. Now, a new tracer could enable surgeons to see and hear prostate cancer.

Researchers at the University of British Columbia (Vancouver, Canada) have developed a new “dual-mode” tracer designed to help image, plan, and guide prostate cancer procedures. The tracer uses a single molecule labeled with Fluorine-18, a common isotope in PET scans, enabling both fluorescence-guided and radio-guided surgery. By combining 18F-organotrifluoroborates with fluorescein, the tracer offers both high-resolution visual guidance and radioactive detection through handheld Geiger counter probes.

The tracer works by targeting PSMA, a protein highly expressed on prostate cancer cells. It demonstrates high tumor uptake for PET imaging and strong optical brightness in fluorescent mode without requiring special visual equipment. Unlike other approaches that require separate injections of different tracers, this method allows clinicians to both see and “hear” radiation signals from cancerous tissue, including lymph nodes or metastases.

In preclinical testing, UBC scientists and collaborators at BC Cancer trialed the tracer on mice implanted with human tumors. The findings, published in the Journal of Medicinal Chemistry, showed high uptake and strong signals in cancerous tissues compared to benign samples, demonstrating feasibility for both diagnostic imaging and surgical guidance.

The dual-mode tracer could reduce unnecessary biopsies, improve the precision of surgery, and expand access to advanced imaging in smaller hospitals with standard equipment. Researchers plan Good Manufacturing Practices assessments, toxicity testing, and validation studies to prepare for human trials. They also suggest potential applications beyond prostate cancer, including ovarian and laryngeal cancers.

“The implementation of dual-mode fluorescent-PET tracers in the surgical field is an exciting new approach to maximize benefit and minimize harm associated with more extended lymph node removal as well as to decrease the rate of positive surgical margins of a radical prostatectomy,” said Dr. Larry Goldenberg, associate director of development and supportive care at the Vancouver Prostate Center and professor of urologic sciences at UBC.

Related Links:
BC Cancer Research
University of British Columbia


New
MRI System
nanoScan MRI 3T/7T
Portable X-ray Unit
AJEX140H
Digital Radiographic System
OMNERA 300M
Diagnostic Ultrasound System
DC-80A
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.